NDC product
Doxycycline Hyclate
NDC 0591-4575 · Actavis Pharma, Inc.
Key facts
| Product NDC | 0591-4575 |
|---|---|
| Proprietary name | Doxycycline Hyclate |
| Nonproprietary name | Doxycycline Hyclate |
| Substances | DOXYCYCLINE HYCLATE |
| Dosage form | TABLET, DELAYED RELEASE |
| Route | ORAL |
| Labeler | Actavis Pharma, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA090134 |
| Pharmacologic classes | Tetracycline-class Drug [EPC], Tetracyclines [CS] |
| Marketing start | Aug 14, 2019 |
| Marketing end | Jun 30, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory